Olgu Sunumu
BibTex RIS Kaynak Göster

Sistemik Lupus Eritematozusa Bağlı Sekonder Antifosfolipid Antikor Sendromu: Superior Mezenterik Arter Tutulumuyla Seyreden Olgu Sunumu

Yıl 2024, , 126 - 129, 29.04.2024
https://doi.org/10.46332/aemj.1114233

Öz

Antifosfolipid antikor sendromu (AFAS); antifosfolipid protein antikor pozitifliği yanı sıra rekurren vasküler tromboz ve/veya gebelik kayıpları ile karakterize bir hastalıktır. Altta yatan bir hastalık saptanmadığında primer tip; altta yatan başka bir romatolojik hastalık varlığında sekonder tip olarak sınıflandırılır. Sekonder AFAS, en sık sistemik lupus eritematozusa (SLE) bağlı gelişir. Burada, AFAS’ta superior mezenterik arter tutulumuna bağlı iskemik kolit vakasını sunduk. 59 yaşında SLE tanısı bulunan kadın hastaya, ani gelişen hematokezya ve akut batın kliniği olması üzerine çekilen kontrastlı bilgisayarlı tomografi anjiografide (BT-anjiografi) superior mezenterik arterde tromboz saptandı. Bu olgu AFAS’a bağlı gastrointestinal sistemdeki farklı damar tutulumu ve tedavi stratejisi açısından ilginçti.

Kaynakça

  • 1. Negrini S, Pappalardo F, Murdaca G, Indiveri F, Puppo F. The anti phospholipid syndrome: from pathophysiology to treatment. Clin Exp Med. 2017;17(3):257-267.
  • 2. Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The anti phospholipid syndrome in patients with systemic lupuserythematosus. J Autoimmün. 2017;76(1):10-20.
  • 3. Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Management of anti phospholipid syndrome. Ann Rheum Dis. 2019;78(2):155-161.
  • 4. Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford). 2007;46(11):1641-1647.
  • 5. Yayla ME, Yüksel M, Şahin D, et. al. Clinical Features of Patients with Anti phospholipid Syndrome and Differences of Patients with Recurrent Thrombosis, A Single Center Retrospective Study. J Ankara Univ Fac Med. 2021;74(1):52-59.
  • 6. Bagger PV, Andersen V, Baslund B, et. al. Anti-cardiolipin Antibodies (IgG and IgA) in Women with Recurrent Fetal Loss Correlate to Clinical and Serological Characteristics of SLE. Acta Obstet Gynecol Scand. 1993;72(6):465-469.
  • 7. England RJA, Woodcock B, Zeiderman MR. Superior Mesenteric Artery Thrombosis in a Patient with the Anti phospholipid Syndrome. Eur J Vasc Endovasc Surg. 1995;10(3): 372-373.
  • 8. Kaushik S, Federle MP, Schur PH, Krishnan M, Silverman SG, Ros PR. Abdominal Thrombotic and Ischemic Manifestations of the Anti phospholipid Antibody Syndrome: CT Findings in 42 Patients. Radiology. 2001;218(3):768-771.
  • 9. Kerzmann A , Haumann A , Boesmans E , Detry O, Defraigne JO. Acute mesenteric ischemia. Rev Med Liege. 2018;73(5-6):300-303.
  • 10. Tektonidou MG, Andreoli L, Limper M, et. al. EULAR recommendations for the management of anti phospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296-1304.

Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report with Superior Mesenteric Artery Involvement

Yıl 2024, , 126 - 129, 29.04.2024
https://doi.org/10.46332/aemj.1114233

Öz

Antiphospholipid antibody syndrome (APS); is a disease characterized by anti-phospholipid protein antibody positivity as well as recurrent vascular thrombosis and/or pregnancy loss. When no underlying disease is detected, it is classified as primary type; when there is another underlying rheumatologic disease, it is classified as secondary type. Secondary APS, most commonly develops due to systemic lupus erythematosus (SLE). We present a case of ischemic colitis due to superior mesenteric artery involvement in APS. 59-year-old female patient diagnosed with SLE had sudden-onset hematochezia and acute abdomen. Therefore, the patient underwent contrast-enhanced computed tomography angiography (CT angiography). Thrombosis was detected in the superior mesenteric artery. This case was interesting in terms of different vascular involvement and treatment strategy in the gastrointestinal tract due to APS.

Kaynakça

  • 1. Negrini S, Pappalardo F, Murdaca G, Indiveri F, Puppo F. The anti phospholipid syndrome: from pathophysiology to treatment. Clin Exp Med. 2017;17(3):257-267.
  • 2. Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The anti phospholipid syndrome in patients with systemic lupuserythematosus. J Autoimmün. 2017;76(1):10-20.
  • 3. Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Management of anti phospholipid syndrome. Ann Rheum Dis. 2019;78(2):155-161.
  • 4. Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford). 2007;46(11):1641-1647.
  • 5. Yayla ME, Yüksel M, Şahin D, et. al. Clinical Features of Patients with Anti phospholipid Syndrome and Differences of Patients with Recurrent Thrombosis, A Single Center Retrospective Study. J Ankara Univ Fac Med. 2021;74(1):52-59.
  • 6. Bagger PV, Andersen V, Baslund B, et. al. Anti-cardiolipin Antibodies (IgG and IgA) in Women with Recurrent Fetal Loss Correlate to Clinical and Serological Characteristics of SLE. Acta Obstet Gynecol Scand. 1993;72(6):465-469.
  • 7. England RJA, Woodcock B, Zeiderman MR. Superior Mesenteric Artery Thrombosis in a Patient with the Anti phospholipid Syndrome. Eur J Vasc Endovasc Surg. 1995;10(3): 372-373.
  • 8. Kaushik S, Federle MP, Schur PH, Krishnan M, Silverman SG, Ros PR. Abdominal Thrombotic and Ischemic Manifestations of the Anti phospholipid Antibody Syndrome: CT Findings in 42 Patients. Radiology. 2001;218(3):768-771.
  • 9. Kerzmann A , Haumann A , Boesmans E , Detry O, Defraigne JO. Acute mesenteric ischemia. Rev Med Liege. 2018;73(5-6):300-303.
  • 10. Tektonidou MG, Andreoli L, Limper M, et. al. EULAR recommendations for the management of anti phospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296-1304.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Tıp Bilimleri
Bölüm Vaka Sunumları
Yazarlar

Beliz Karataş 0000-0003-1894-8062

İlker Yalçın 0000-0001-8018-5364

Neşe Çabuk Çelik 0000-0002-9045-7105

Gizem Pire 0000-0003-4009-688X

Hatice Şeyma Eren 0000-0003-3430-9287

Ali Sahin 0000-0002-6953-4276

Erken Görünüm Tarihi 5 Nisan 2024
Yayımlanma Tarihi 29 Nisan 2024
Yayımlandığı Sayı Yıl 2024

Kaynak Göster

APA Karataş, B., Yalçın, İ., Çabuk Çelik, N., Pire, G., vd. (2024). Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report with Superior Mesenteric Artery Involvement. Ahi Evran Medical Journal, 8(1), 126-129. https://doi.org/10.46332/aemj.1114233
AMA Karataş B, Yalçın İ, Çabuk Çelik N, Pire G, Eren HŞ, Sahin A. Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report with Superior Mesenteric Artery Involvement. Ahi Evran Med J. Nisan 2024;8(1):126-129. doi:10.46332/aemj.1114233
Chicago Karataş, Beliz, İlker Yalçın, Neşe Çabuk Çelik, Gizem Pire, Hatice Şeyma Eren, ve Ali Sahin. “Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report With Superior Mesenteric Artery Involvement”. Ahi Evran Medical Journal 8, sy. 1 (Nisan 2024): 126-29. https://doi.org/10.46332/aemj.1114233.
EndNote Karataş B, Yalçın İ, Çabuk Çelik N, Pire G, Eren HŞ, Sahin A (01 Nisan 2024) Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report with Superior Mesenteric Artery Involvement. Ahi Evran Medical Journal 8 1 126–129.
IEEE B. Karataş, İ. Yalçın, N. Çabuk Çelik, G. Pire, H. Ş. Eren, ve A. Sahin, “Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report with Superior Mesenteric Artery Involvement”, Ahi Evran Med J, c. 8, sy. 1, ss. 126–129, 2024, doi: 10.46332/aemj.1114233.
ISNAD Karataş, Beliz vd. “Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report With Superior Mesenteric Artery Involvement”. Ahi Evran Medical Journal 8/1 (Nisan 2024), 126-129. https://doi.org/10.46332/aemj.1114233.
JAMA Karataş B, Yalçın İ, Çabuk Çelik N, Pire G, Eren HŞ, Sahin A. Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report with Superior Mesenteric Artery Involvement. Ahi Evran Med J. 2024;8:126–129.
MLA Karataş, Beliz vd. “Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report With Superior Mesenteric Artery Involvement”. Ahi Evran Medical Journal, c. 8, sy. 1, 2024, ss. 126-9, doi:10.46332/aemj.1114233.
Vancouver Karataş B, Yalçın İ, Çabuk Çelik N, Pire G, Eren HŞ, Sahin A. Secondary Antiphospholipid Antibody Syndrome Due to Systemic Lupus Erythematosus: A Case Report with Superior Mesenteric Artery Involvement. Ahi Evran Med J. 2024;8(1):126-9.

Dergimiz, ULAKBİM TR Dizin, DOAJ, Index Copernicus, EBSCO ve Türkiye Atıf Dizini (Turkiye Citation Index)' de indekslenmektedir. Ahi Evran Tıp dergisi süreli bilimsel yayındır. Kaynak gösterilmeden kullanılamaz. Makalelerin sorumlulukları yazarlara aittir.

Creative Commons Lisansı
Bu eser Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.